Atosiban acetate

阿托西班醋酸盐

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAtosiban acetate
Drug Alias NameAntocin II醋酸阿托西班人阿托西班催产素atosibanumAntocile +[15
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionOxytocin receptor antagonists
TargetsOxytocin receptor
Therapy Area/IndicationsPremature BirthObstetric Labor, PrematureEndometriosis
Global Approved IndicationsPremature BirthObstetric Labor, Premature
Approved Indications in ChinaObstetric Labor, Premature
Original Approved Country/TerritoryEU
Original Approved Date2000/01/20
Country/TerritoryNetherlandsEUMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active IndicationsPremature BirthObstetric Labor, Premature
Inactive IndicationsEndometriosis

Other Information

ATC CodeG02CX01
Related LinksWikipediaKEGG